Two new drugs being studied at Wash U study could help Alzheimer’s patients (Links to an external site)
The fight against Alzheimer’s: ‘Every Minute Counts’ reveals latest developments (Links to an external site)
Alzheimer’s disease affects more than 5 million Americans. Neurologist Dr. Rudy Tanzi and Daisy Duarte, whose mother is in the final stages of Alzheimer’s, talk to Kathie Lee Gifford and Jenna Bush Hager about the new PBS documentary “Every Minute Counts,” which reveals the latest developments in the fight against the devastating illness.
The New Offensive on Alzheimer’s disease: Stop it before it Starts (Links to an external site)
Alzheimer’s-Every Minute Counts (Links to an external site)
WashU early AD initiative could yield broader clues (Links to an external site)
If intervening ahead of symptoms in Alzheimer’s disease (AD) works in people with gene mutations that predispose them to getting sick at a younger age, then it will probably work in the rest of the population, principal investigator Randall Bateman theorized to BioWorld Today, and his team at Washington University (WashU) – testing drugs provided […]
Early Alzheimer’s Gene Is A Curse For Families, A Gift For Science (Links to an external site)
Landmark Alzheimer’s prevention trial to evaluate third drug (Links to an external site)
An international study to test drugs that may prevent or delay Alzheimer’s disease is adding a third drug arm. Participants who receive the drug or placebo will be monitored for at least four years for signs of the disease.
The Alzheimer’s Laboratory (Links to an external site)
A changing landscape: Alzheimer’s disease, research and the future of care (Links to an external site)
Ongoing international research led by Washington University investigators is changing the Alzheimer’s disease landscape from hopeless to hopeful.
Eli Lilly’s Experimental Alzheimer’s Drug Fails in Large Trial (Links to an external site)
An experimental Alzheimer’s drug that had previously appeared to show promise in slowing the deterioration of thinking and memory has failed in a large Eli Lilly clinical trial, dealing a significant disappointment to patients hoping for a treatment that would alleviate their symptoms.
Dominantly Inherited Alzheimer Network Trial (DIAN-TU-001) continues despite results from Eli Lilly and Company’s EXPEDITION3 trial (Links to an external site)
German Families with Dominantly Inherited Alzheimer’s Disease Meet for the First Time (Links to an external site)
Nobody knew each other’s name. Even so, 60 people who either were at risk of having an autosomal-dominant Alzheimer’s mutation, or were accompanying someone who was, exchanged information about a shared problem. There were moments of validation—“Denial has divided my family, too!”—and apprehensive questions—“Do you want to know if you have it?”
Why Most Alzheimer’s Research Is Done On Early-Onset Patients Like Pat Summitt (Links to an external site)
$4 million grant expands major study to find Alzheimer’s prevention treatments (Links to an external site)
Washington University School of Medicine in St. Louis has received a $4.3 million award from the Alzheimer’s Association to expand a major international clinical trial evaluating whether drugs can prevent Alzheimer’s disease in patients genetically predisposed to develop the devastating disease at a young age.
Family places hope in drug trial for hereditary Alzheimer’s gene mutation (Links to an external site)
Alzheimer’s Disease: Daisy’s Story (Links to an external site)
Man looking for answers with new Alzheimer’s study (Links to an external site)
He has the disease and he’s lost five family members to it, now he’s enrolled in a study hoping to find some answers in Alzheimer’s disease.
Trial aims to prevent Alzheimer’s in those genetically predisposed (Links to an external site)
A first-of-its-kind study is testing the use of antibody drugs to prevent or slow down the onset of Alzheimer’s disease in individuals genetically destined to develop the illness at an early age.
Screening for Alzheimer’s Gene Tests the Desire to Know (Links to an external site)
The Hardest Test: Tucson family has hereditary Alzheimer’s (Links to an external site)
Dominantly Inherited Alzheimer’s Network-Trials Unit on PBS (Links to an external site)
Brian and Amelia Cottle’s story: Living with early onset Alzheimer’s disease (Links to an external site)
Dominantly Inherited Alzheimer Network Trial Completes Participant Enrollment for Two Drugs in Phase II/III Study of Amyloid Therapies (Links to an external site)
2015 Update
The Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) has completed the first stage of participant enrollment in the first Alzheimer’s prevention trial for autosomal dominant Alzheimer’s disease (ADAD), also referred to as early-onset Alzheimer’s disease. The goal of the first stage of the study is to determine the biomarker and cognitive effects of two different […]
34-year-old woman travels to Wash U for Alzheimer’s trial (Links to an external site)
A devastating disease that can rob you of your memory has an Alabama woman traveling to Missouri for help. The mother of three is taking part in a ground breaking study led by Washington University. Carrie Richardson, a 34-year-old preschool teacher and mother of three is in the fight of her life.
First trial to stop Alzheimer’s before symptoms emerge (Links to an external site)
Most research into dementia is about finding treatments for people who are already affected by symptoms. But a trial is under way in London which aims to prevent Alzheimer’s in people at high risk, before they show any physical signs of the disease.
Family with history of rare Alzheimer’s gene hopes for a cure (Links to an external site)
Can knowing you and your family may get Alzheimer’s ever be positive? (Links to an external site)
At the University of Washington’s School of Medicine there is a computer database that states with certainty – albeit heavily encrypted – whether or not Sophie Leggett will develop a form of genetically inherited early onset Alzheimer’s disease. But she has chosen not to find out what it says.
Slipping Away (Links to an external site)
Alzheimer’s: Experimental drug offers hope to families with legacy of degenerative brain disease (Links to an external site)
